The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease
Open accessThe DOI matches its Crossref record; 131 of the 134 references it cites were found in a registry or an index.
Abstract
The development of culture-independent techniques for microbiological analysis has uncovered the previously unappreciated complexity of the bacterial microbiome at various anatomic sites. The microbiome of the lung has relatively less bacterial biomass when compared with the lower gastrointestinal tract yet displays considerable diversity. The composition of the lung microbiome is determined by elimination, immigration, and relative growth within its communities. Chronic lung disease alters these factors. Many forms of chronic lung disease demonstrate exacerbations that drive disease progression and are poorly understood. Mounting evidence supports ways in which microbiota dysbiosis can influence host defense and immunity, and in turn may contribute to disease exacerbations. Thus, the key to understanding the pathogenesis of chronic lung disease may reside in deciphering the complex interactions between the host, pathogen, and resident microbiota during stable disease and exacerbations. In this brief review we discuss new insights into these labyrinthine relationships.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For instance, the lungs’ surface approximates 1 m2/kg of body weight and is not sterile (108).”
From The microbiome and human cancer (2021) · cites this paper as [108]
In the citing paper
“metabolites produced by the microbiota could have an important immunoregulatory function specifically targeting the IL-1 axis (590, 591).”
From Aspergillus fumigatus and Aspergillosis in 2019 (2019) · cites this paper as [590]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Human gut microbiome viewed across age and geography
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R. N., Anokhin, A. P., et al. (2012) · Nature · doi:10.1038/nature11053 · Cited by 7,815
Enterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548
Dominguez-Bello, M. G., Costello, E. K., Contreras, M., Magris, M., Hidalgo, G., Fierer, N., & Knight, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002601107 · Cited by 4,774
Grice, E. A., & Segre, J. A. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2537 · Cited by 3,143
Gut Microbiota Metabolism of Dietary Fiber Influences Allergic Airway Disease and Hematopoiesis
Trompette, A., Gollwitzer, E. S., Yadava, K., Sichelstiel, A. K., Sprenger, N., Ngom-Bru, C., Blanchard, C., Junt, T., Nicod, L. P., Harris, N. L., et al. (2014) · Nature Medicine · doi:10.1038/nm.3444 · Cited by 2,862
MICROBIAL ECOLOGY OF THE GASTROINTESTINAL TRACT
Savage, D. C. (1977) · Annual Review of Microbiology · doi:10.1146/annurev.mi.31.100177.000543 · Cited by 2,436
Community study of role of viral infections in exacerbations of asthma in 9–11 year old children
Johnston, S. L., Pattemore, P. K., Sanderson, G., Smith, S., Lampe, F., Josephs, L., Symington, P., Toole, S. O., Myint, S. H., Tyrrell, D. A. J., et al. (1995) · BMJ · doi:10.1136/bmj.310.6989.1225 · Cited by 1,991
Raghu, G., Rochwerg, B., Zhang, Y., Garcia, C. A. C., Azuma, A., Behr, J., Brozek, J. L., Collard, H. R., Cunningham, W., Homma, S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1063st · Cited by 1,916
Cited by
Items 201–300 of 362
Wee, J. H., Min, C., Jung, H. J., Park, M. W., & Choi, H. G. (2021) · Rhinology Journal · doi:10.4193/rhin21.141 · Cited by 12
He, Y., Li, J., Yu, W., Zheng, Y., Yang, D., Xu, Y., Zhao, L., Ma, X., Gong, P., & Gao, Z. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.943317 · Cited by 11
“The LRT microbiota is crucial for the host immune system, and the imbalance between microbial migration and removal is correlated with alveolar and systematic inflammation (O’Dwyer et al., 2016).”
BackgroundGut–Lung Microbiota Interaction in COPD Patients: A Literature Review
Krūmiņa, A., Bogdanova, M., Gintere, S., & Vīksna, L. (2022) · Medicina · doi:10.3390/medicina58121760 · Cited by 14
Calyeca, J., Balderas-Martínez, Y. I., Selman, M., & Pardo, A. (2021) · Aging · doi:10.18632/aging.203039 · Cited by 11
“Evidence has shown the loss of diversity of lung microbiota with increasing age together with age-dysregulation of the immune response and other factors plausibly contributes to the process of inflammaging [29, 30].”
The forgotten oral microbial transplantation for improving the outcomes of COVID-19
AbdelMassih, A. F., Gadalla, M., Hussein, E., ElAhmady, M., Zahra, N., Eid, M. A., Hussein, M., Hassan, A. A., Abouzeid, A., Hassan, A., et al. (2021) · New Microbes and New Infections · doi:10.1016/j.nmni.2021.100923 · Cited by 10
“org/lice the lungs is found in abundance in the upper respiratory tract and oropharynx, which has a direct form of association with the lungs [9].”
Host-microbe interactions at barrier tissues and immunomodulation: a scoping review
Chigozie, V. U., Enyi, E. O., Akwari, A. A., & Esimone, C. O. (2025) · Discover Bacteria. · doi:10.1007/s44351-025-00037-3 · Cited by 14
Shumyatsky, G., Burrell, A., Chaney, H. R., Sami, I. R., Koumbourlis, A. C., Freishtat, R. J., Crandall, K. A., Zemanick, E. T., & Hahn, A. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2022.1082125 · Cited by 10
“This remodeling, combined with the anoxic and acidic conditions characteristic to the CF lung, poses conceivable selective pressures on the lung microbiome (26, 44).”
BackgroundJin, X. E. F., Low, D. Y., Ang, L., Lu, L., Yin, X. H., Tan, Y., Lee, A. K. Y., & Seow, W. J. (2023) · Environmental Research · doi:10.1016/j.envres.2023.116392 · Cited by 11
Yadav, B., Bhattacharya, S. S., Rosen, L., Nagpal, R., Yadav, H., & Yadav, J. S. (2024) · Nanomaterials · doi:10.3390/nano14030314 · Cited by 10
“In human respiratory diseases, there has been increasing evidence of the role of the lung microbiome in inducing immune responses and vice versa [16,18].”
BackgroundFinch, S., Keir, H. R., Dicker, A., & Chalmers, J. D. (2017) · Respirology · doi:10.1111/resp.13106 · Cited by 10
Emerging therapeutic targets and preclinical models for severe asthma
Galvão, I., Kim, R., Shen, S., Budden, K. F., Vieira, A. T., & Hansbro, P. M. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1786535 · Cited by 12
Rofael, S., Brown, J., Pickett, E., Johnson, M. A., Hurst, J. R., Spratt, D. A., Lipman, M. C. I., & McHugh, T. D. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100427 · Cited by 13
“Recent studies have demonstrated that the microbiome has an important role in determining respiratory health and can be a key player in the pathogenesis and prognosis of inflammatory chronic lung disease [6,7].”
BackgroundResultThe environment shapes swine lung bacterial communities
McCumber, A. W., Kim, Y. J., Isikhuemhen, O. S., Tighe, R. M., & Gunsch, C. K. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.143623 · Cited by 9
The potential of bacteriophage therapy in the treatment of paediatric respiratory infections
Jones, J. D., Varghese, D., Pabary, R., & Langley, R. J. (2022) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2022.02.001 · Cited by 18
Arnold, H. K., Hanselmann, R., Duke, S. M., Sharpton, T. J., & Beechler, B. R. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268730 · Cited by 14
“Disrupted gut communities can influence immune responses at distal sites [24, 25], and microbial diversity exposure has been inversely correlated to allergy, asthma and allergic rhinitis development in humans [26–28].”
Backgroundde Carvalho, F. M., Lemos, L. N., Ciapina, L. P., Moreira, R. G., Gerber, A. L., Guimarães, A. P. C., Fereguetti, T., Zambelli, V. A. D. A., de Ávila, R. E., de Almeida, T. B., et al. (2020) · medRxiv · doi:10.1101/2020.12.22.20248501 · Cited by 10
“Our results suggest that COVID-19 reduces microbial diversity and increases the proportion of pathogens, similar to other acute and chronic lung diseases (22).”
ResultSong, M. J., Kim, D. H., Kim, S., Kang, N., & Jhun, B. W. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03308-2 · Cited by 10
“Recently, an association between the respiratory tract microbial environment and respiratory disease has been reported [9, 10], and the microbiome has been used to elucidate the progression or pathogenesis of various respiratory diseases.”
BackgroundThe Microbiota in Immunity and Inflammation
Maynard, C. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-7020-6896-6.00014-4 · Cited by 13
Burgos, H. L., Burgos, E. F., Steinberger, A. J., Suen, G., & Mandel, M. J. (2020) · mSystems · doi:10.1128/msystems.00846-20 · Cited by 10
Peripheral blood microbial signatures in current and former smokers
Morrow, J. D., Castaldi, P. J., Chase, R., Yun, J. H., Lee, S., Liu, Y., Hersh, C. P., & the COPDGene Investigators (2021) · Scientific Reports · doi:10.1038/s41598-021-99238-4 · Cited by 10
Hyperammonemia in lung transplant patients and its management: a review
Kumar, A., Advani, S., Kichloo, A., Mohamed, M. A., Wani, F., Singh, J., Albosta, M. S., Shiwalkar, N., & Keshavamurthy, S. (2022) · Indian Journal of Thoracic and Cardiovascular Surgery · doi:10.1007/s12055-021-01319-6 · Cited by 9
“While the role of gut microbiota has been established in chronic lung diseases, its significance in ischemia reperfusion injury and lung rejection is only recently recognized and is being extensively researched [43].”
BackgroundAnalysis of airway microbiota in adults from a Brazilian cystic fibrosis center
Leite, C. C. F., de Freitas, F. A. D., Firmida, M. D. C., Leão, R. S., Albano, R. M., & Marques, E. A. (2020) · Brazilian Journal of Microbiology · doi:10.1007/s42770-020-00381-3 · Cited by 8
Curtis, A., Ryan, M., & Kavanagh, K. A. (2023) · Journal of Fungi · doi:10.3390/jof9020222 · Cited by 8
The pathogenesis of ventilator-associated pneumonia: old and new mechanisms
Ulsamer, A., Bonilla-Pellegrini, S., Pérez-Fernández, X. L., Rello, J., & Sabater‐Riera, J. (2025) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2025.2493366 · Cited by 14
“Several other studies confirmed the ability of the microbiota to modulate the TLR4/NF-κB pathway and vice versa, thereby preventing inflammation and lung injury [143–146].”
Subgingival microbial diversity and respiratory decline: A cross‐sectional study
Winning, L., Moran, G. P., McClory, M., Karim, I. A. E., Lundy, F. T., Patterson, C., Linden, D. A., Cullen, K. M., Kee, F., & Linden, G. J. (2023) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13819 · Cited by 7
Karaś, M. A., Turska-Szewczuk, A., Janczarek, M., & Szuster‐Ciesielska, A. (2019) · Innate Immunity · doi:10.1177/1753425918821168 · Cited by 9
“inflammatory as well as infectious diseases.(187,188) Recently, increasing evidence suggests that the alterations in the lung microbiome constitution are associated with severity of pulmonary diseases such as asthma or chronic obstructive pulmonary disease (COPD).”
BackgroundSmoking induces shifts in cellular composition and transcriptome within the bronchial mucus barrier
Rathnayake, S. N. H., Ditz, B., van Nijnatten, J., Sadaf, T., Hansbro, P. M., Brandsma, C., Timens, W., van Schadewijk, A. M., Hiemstra, P. S., ten Hacken, N. H. T., et al. (2022) · Respirology · doi:10.1111/resp.14401 · Cited by 11
“COPD patients with enhanced sputum mucus viscosity exhibit higher rates of respiratory exacerbations, which might be caused by altered microbiome dynamics.(6,7) Interestingly, it has been shown that smoking cessation in mild COPD patients and non-COPD controls is associated with reduced respiratory symptoms and less b…”
BackgroundA Perspective on Lung Cancer and Lung Microbiome: Insight on Immunity
Emadi, R., Saki, S., Yousefi, P., & Tabibzadeh, A. (2025) · Immunity Inflammation and Disease · doi:10.1002/iid3.70145 · Cited by 8
The Effects of Immunosuppression on the Lung Microbiome and Metabolites in Rats
Dong, H., Tan, R., Chen, Z., Wang, L., Song, Y., Jin, M., Yin, J., Li, H., Lǐ, J., & Yang, D. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.817159 · Cited by 7
“We speculate that the immunosuppressive effect of cyclophosphamide on immune cells such as neutrophils and lymphocytes weakens their ability to remove foreign bacteria entering the lungs, thus making it easier for mistakenly swallowed bacteria to survive and lead to changes in the flora of the patients’ lungs (O’Dwyer…”
BackgroundInfluentialO’Dwyer, D. N., & Garantziotis, S. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202007-2822ed · Cited by 8
“, perfumes and cleaning products) and use of their voice (3).”
BackgroundSelf-citationThe Microbiome and Pulmonary Immune Function
Baker, J. M., & Dickson, R. P. (2024) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2024.10.006 · Cited by 6
Self-citationProbiotics: An adjuvant treatment strategy for chronic respiratory diseases
Verma, B., Kumar, N., Ashique, S., Debnath, B., Garg, A., Mishra, N., Mojgani, N., Kaurav, M., Gupta, M., Bhowmick, M., et al. (2025) · Respiratory Medicine · doi:10.1016/j.rmed.2025.108268 · Cited by 8
Wang, Y., Li, X., & Gao, F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1549865 · Cited by 9
Rukonge, P. A., Kawuribi, V., Sheng, Y., Wei, Q., Kun, Y., Niyodukunda, P., Wang, T., Lu, Z., Miao, Y., Xu, K., et al. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.105094 · Cited by 9
Berry, S. B., Haack, A. J., Theberge, A. B., Brighenti, S., & Svensson, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00537 · Cited by 7
“components such as an air-exposed epithelium, a structurally intrinsic extracellular matrix, a complex vasculature network, and a myriad of immune components (203) (Figure 1), as well as a unique microbiome that contributes to the exchange of chemical signals in this microenvironment (6, 204, 205).”
BackgroundThe Oral–Lung Microbiome Axis in Connective Tissue Disease-Related Interstitial Lung Disease
Bongers, K. S., Massett, A., & O’Dwyer, D. N. (2024) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0044-1785673 · Cited by 7
“16 20 Intrigu-ingly, dysbiosis of the oral microbiome is also associatedwith disease severity and mortality in IPF.”
BackgroundSelf-citationYan, Q., Xing, J.-H., Zou, R., Sun, M., Zou, B., Wang, Y., Niu, T., Yu, T., Huang, H., Yang, W., et al. (2024) · Veterinary Research · doi:10.1186/s13567-024-01391-x · Cited by 6
World Lung Day: what, why, and where to?
Fong, K. M., Welte, T., & (FIRS), F. T. F. O. I. R. S. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00364.2020 · Cited by 6
Understanding the Relationship of the Human Bacteriome with COVID-19 Severity and Recovery
Zafar, H., & Saier, M. H. (2023) · Cells · doi:10.3390/cells12091213 · Cited by 6
Prophages: an integral but understudied component of the human microbiome
Inglis, L. K., Roach, M. J., & Edwards, R. A. (2024) · Microbial Genomics · doi:10.1099/mgen.0.001166 · Cited by 15
“The overall bacterial concentration estimates suggest the mouth has more bacteria than the lungs [9, 36], which is generally conducive to higher rates of lysogeny.”
BackgroundMicrobiota and chronic lung disease in preterm infants. Where is the truth?
Nandakumar, V., & Aly, H. Z. (2020) · Journal of Perinatology · doi:10.1038/s41372-020-0666-5 · Cited by 6
Beyond the organ: lung microbiome shapes transplant indications and outcomes
Ponholzer, F., Bogensperger, C., Krendl, F. J., Krapf, C., Dumfarth, J., Schneeberger, S., & Augustin, F. (2024) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezae338 · Cited by 5
The intricate interactions between the lungs and gut in patients: unraveling the crosstalk mechanism
Li, J., Chen, Y., & Hu, B. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1624907 · Cited by 5
Buruiană, G., Sima, C. M., Anton-Păduraru, D.-T., Bădescu, A. C., Luncă, C., Duhaniuc, A., & Dorneanu, O. (2025) · Medicina · doi:10.3390/medicina61091605 · Cited by 7
“This groundbreaking work revealed that the lower respiratory tract harbors a complex, dynamic microbial ecosystem characterized by low biomass and high turnover, with metabolically active bacterial communities that exhibit distinct compositional patterns [21].”
Taherkhani, H., KavianFar, A., Aminnezhad, S., Lanjanian, H., Ahmadi, A., Jamalkandi, S. A., & Masoudi‐Nejad, A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24775 · Cited by 7
Benčič, A., Toplak, N., Koren, S., Košir, A. B., Milavec, M., Tomič, V., Lužnik, D., & Dreo, T. (2024) · mSystems · doi:10.1128/msystems.00735-24 · Cited by 5
AB569, a nontoxic chemical tandem that kills major human pathogenic bacteria
McDaniel, C. T., Panmanee, W., Winsor, G. L., Gill, E. E., Bertelli, C., Schurr, M. J., Dongare, P., Paul, A. T., Ko, S.-H. B., Lau, G. W., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1911927117 · Cited by 5
“Additionally, moving into in vivo models should prompt an investigation on the impacts of the treatment on the lung microbiome, both from a homeostatic microbiome standpoint (30, 31) and as it has been recently noted that the microbiome may have a larger impact on host biology through interactions with microRNAs (32).”
BackgroundDubowski, K., Kaali, S., Jack, D. W., Prah, R. K. D., Clemente, J. C., Tawiah, T. A. S., Mujtaba, M. N., Iddrisu, L. F., Carrión, D., Konadu, D. G., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18147276 · Cited by 6
Cavalcante, G. G., Guimarães, A. G., Queiroz, C. P., Gonçalves-Pereira, M. H., Dias, A. S. L., Horta, L. S., de Oliveira, J. S., Cangussú, S. D., Magalhães, P. P., Russo, R. C., et al. (2022) · Journal of Immunology Research · doi:10.1155/2022/1466011 · Cited by 5
Changes in sputum microbiota during treatment for nontuberculous mycobacterial pulmonary disease
Kim, B., Yu, J. Y., Kim, S., Kim, D. H., & Jhun, B. W. (2023) · Scientific Reports · doi:10.1038/s41598-023-47230-5 · Cited by 6
Smith, S. A., Ropati, D. V., Santoferrara, L. F., Romano, T. A., & McManus, G. B. (2023) · Frontiers in Marine Science · doi:10.3389/fmars.2023.1168623 · Cited by 5
Community-Acquired Pneumonia Pathogenesis in Patients with Chronic Obstructive Pulmonary Disease
Ramírez, J. A. (2019) · The University of Louisville Journal of Respiratory Infections · doi:10.18297/jri/vol3/iss2/4 · Cited by 4
“In the COPD patient there are alterations in the number and types of organisms present in the lung microbiome, a phenomenon known as dysbiosis [5].”
BackgroundImmunometabolic control by Klebsiella pneumoniae
Prince, A. S., & Lung, T. W. F. (2023) · Immunometabolism · doi:10.1097/in9.0000000000000028 · Cited by 9
“While the T6SS is best characterized for its role in killing non-kin bacterial competitors, its role in mounting an antioxidant response to mediate bacterial survival may be more relevant in the airway than interbacterial killing given the sparse lung microbiome [81].”
BackgroundZhou, X., & Moore, B. B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.718603 · Cited by 3
Self-citationSterrett, J. D., Andersen, N. D., & Lowry, C. A. (2022) · Progress in inflammation research · doi:10.1007/978-3-030-91051-8_10 · Cited by 4
Prophage rates in the human microbiome vary by body site and host healthPreprint
Inglis, L. K., Roach, M. J., & Edwards, R. A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.04.539508 · Cited by 4
Li, J., Huang, T., Zhang, M., Tong, X., Chen, J., Zhang, Z., Huang, F., Ai, H., & Huang, L. (2023) · International Microbiology · doi:10.1007/s10123-023-00345-1 · Cited by 6
Impact of Respiratory Bacterial Findings on Patients with Chronic Pulmonary Aspergillosis
Cho, H. K., Moon, S. M., Kim, H., & Shin, B. (2024) · International Journal of Microbiology · doi:10.1155/2024/1329884 · Cited by 3
Nanomedicine at the Pulmonary Frontier: Immune-Centric Approaches for Respiratory Disease Treatment
Kaur, J. K., Sharma, A., Passi, G., Dey, P., Khajuria, A., Alajangi, H. K., Jaiswal, P. K., Barnwal, R. P., & Singh, G. (2024) · Immunological Investigations · doi:10.1080/08820139.2023.2298398 · Cited by 3
Idiopathic Pulmonary Fibrosis: What Is the Best Treatment?
Martínez, F. J., Kaner, R. J., & Wu, X. (2017) · Barcelona Respiratory Network · doi:10.23866/brnrev:2017-m0041 · Cited by 3
Ibrahim, J. W., Garantziotis, S., & Savani, R. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-68353-1.00009-9 · Cited by 3
The Microbiota in Immunity and Inflammation
Maynard, C. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8165-1.00022-8 · Cited by 3
Hutton, A. J., Warner, J. A., & Staples, K. J. (2018) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2018026611 · Cited by 2
A visualization analysis of immune-related adverse reactions in pulmonary carcinoma
Gong, Y., Kang, J., Wang, M., Hayati, M. F. M., Goh, L. P. W., & Rahim, S. S. B. S. A. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2429237 · Cited by 2
Effect of epinephrine on growth characteristics of Actinobacillus pleuropneumoniae field isolates
Schreiber, E., Freise, F., de Buhr, N., & Hennig‐Pauka, I. (2025) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2025.107193 · Cited by 2
Lv, J.-X., Pei, Y.-Y., Yang, C., Liu, X., Ju, M., Holmes, E. C., Chen, Y., Zhu, T., & Zhang, Y. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013667 · Cited by 2
Interactions between Mycoplasma hyopneumoniae strains and the resident lung microbiota in swine
Toledo, L. T., Polveiro, R. C., Silva-Júnior, A., Moreira, M. A. S., & Marks, F. S. (2025) · Veterinary Microbiology · doi:10.1016/j.vetmic.2025.110840 · Cited by 2
Thomsen, C. M. K., Kromann-Thomsen, S., Thim, S. B., & Rubak, S. (2026) · European Respiratory Review · doi:10.1183/16000617.0071-2025 · Cited by 2
“Microbial studies of low-biomass samples, as found in BAL, are highly susceptible to contamination from reagents, equipment and upper-airway microbiota, which can skew results if not properly controlled with “ no template ” controls [79].”
Gut microbiota dysbiosis and the gut–lung axis: links to asthma and its common comorbidities
Xie, J., & Yu, J. (2026) · PeerJ · doi:10.7717/peerj.20960 · Cited by 3
“Despite rapid growth in this field, an integrated synthesis connecting gut microbiota dysbiosis to asthma and its major comorbidities remains limited ( O’Dwyer, Dickson & Moore, 2016 ).”
SwarmGenomics : A Unified Pipeline for Individual‐Based Whole‐Genome Analyses
Kylmänen, A., Chen, Y., Tehrani, S. J., Vellnow, N., Wilcox, J. J. S., & Gossmann, T. I. (2026) · Molecular Ecology Resources · doi:10.1111/1755-0998.70119 · Cited by 2
Cefalì, M., Efstathopoulou, A., Dosso, S. D., & Saletti, P. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105982 · Cited by 2
Lung Microbiome: Friend or Foe of Mycobacterium tuberculosis
Perveen, S., & Sharma, R. (2022) · Springer eBooks · doi:10.1007/978-981-16-8957-4_12 · Cited by 4
Respiratory Delivery of Probiotics to Improve Lung Health
Byun, A. S., Vitetta, L., Chan, H., & Kwok, P. C. L. (2023) · AAPS introductions in the pharmaceutical sciences · doi:10.1007/978-3-031-47567-2_7 · Cited by 6
The microbiome and lung cancer: microbial effects on host immune responses and treatment outcomes
Bailey, A., Leuther, K. K., & Robinson, L. A. (2025) · Frontiers in Microbiomes · doi:10.3389/frmbi.2025.1606551 · Cited by 5
“Substantial evidence indicates that local lung dysbiosis is linked to chronic pulmonary diseases often causing signi fi cant in fl ammation in the lungs (O ’ Dwyer et al., 2016).”
Liposomal Inhalation after Tracheostomy—A Randomized Controlled Trial
Hofauer, B. G., Straßen, U., Chaker, A. M., Schossow, B., Wirth, M., Wirth, M., Baş, M., & Knopf, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153312 · Cited by 2
Gut-lung cross talk in COVID-19 pathology and fatality rate
El-Ansary, A. K., Balto, H. A. G., & Al‐Hadlaq, S. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90769-9.00037-2 · Cited by 2
The Microbiome in Acute Lung Injury and ARDS
Kitsios, G. D., Franz, C. A., & McVerry, B. J. (2022) · Respiratory medicine · doi:10.1007/978-3-030-87104-8_11 · Cited by 1
Microbiome in Inflammatory Lung Diseases: Challenges and Future Prospects
Verma, N., Thapa, K., & Dua, K. (2022) · Springer eBooks · doi:10.1007/978-981-16-8957-4_19 · Cited by 3
Aroylated phenylenediamine HO53 modulates innate immunity, histone acetylation and metabolism
Barrier, M. L., Myszor, I. T., Sahariah, P., Sigurðsson, S., Carmena‐Bargueño, M., Pérez‐Sánchez, H., & Gudmundsson, G. H. (2023) · Molecular Immunology · doi:10.1016/j.molimm.2023.02.003 · Cited by 2
Jacobs, S., Payne, C., Shaboodien, S., Kgatla, T., Pretorius, A., Jumaar, C., Sanni, O., BUTROUS, G. S., & Maarman, G. J. (2023) · Pulmonary Circulation · doi:10.1002/pul2.12277 · Cited by 1
“The microbiota play a role in modulating immune function in the prevention and progression of chronic respiratory diseases.(79,80) Therefore, there is a crosstalk between the lungs and gut microbiota.”
BackgroundPathophysiology, Immunology, and Histopathology of Bronchiectasis
Menéndez, R., & Sibila, O. (2017) · Springer eBooks · doi:10.1007/978-3-319-61452-6_5 · Cited by 3
Sekyere, J. O., Maningi, N. E., Matukane, S. R., Mbelle, N. M., & Fourie, P. B. (2021) · medRxiv · doi:10.1101/2021.06.24.21259332 · Cited by 1
Multi-omics in Study of Lung Microbiome
Roy, D., Roy, P., & Saha, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-1844-3_12 · Cited by 2
Hossain, F. M. A., Zinnah, K. M. A., Osman, H., & Manandhar, K. D. (2025) · Allergy medicine. · doi:10.1016/j.allmed.2025.100061 · Cited by 1
Urban Aerosols, the Microbiome, and the Rise of "Urban Atopy"
Mkilima, T. (2025) · Aerosol Science and Engineering · doi:10.1007/s41810-025-00331-2 · Cited by 3
“The lung microbiome consists of a diverse community of microorganisms that play a key role in immune modulation and protecting against pathogenic bacteria and viruses (O’Dwyer et al. 2016).”
Microbial extracellular vesicles in the lung: friends in health, agents in disease
Pagnini, M., Conti, M., Puddu, G., Daverio, M., Celi, A., Bazzan, E., & Neri, T. (2026) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2025.139 · Cited by 1
Baurzhan, M. B., Gulyayev, A. E., Absattarova, K. S., Kairgeldina, S. A., Аbzaliyev, K., Izbassarova, A., Lepessova, M., & Absatarova, K. (2026) · Diseases · doi:10.3390/diseases14060201 · Cited by 3
Bacteria in the Genitourinary Tract: The Microbiota and Efforts to Address Infection
Gao, T., & Scotland, K. B. (2019) · Springer eBooks · doi:10.1007/978-3-030-17542-9_1 · Cited by 3
Microbiome Therapeutics in Respiratory Illnesses
Shariff, M., & Aditi (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00002-4 · Cited by 1
The Gut Microbiome in Serious Mental Illnesses
Tzavellas, E., Logotheti, M., & Stefanis, N. C. (2021) · The microbiomes of humans, animals, plants, and the environment · doi:10.1007/978-3-030-59642-2_8 · Cited by 1
Microbiome in Chronic Obstructive Pulmonary Disease (COPD)
Chandran, C. S., Subin, A. J., Raj, A., Swathy, K. K., & Raghunath, I. (2022) · Springer eBooks · doi:10.1007/978-981-16-8957-4_6 · Cited by 1
Ktena, Y. P., & Cooke, K. R. (2023) · Springer eBooks · doi:10.1007/978-3-031-28797-8_31 · Cited by 1
Lushington, G. H., Linde, A., & Melgarejo, T. (2023) · BioTech · doi:10.3390/biotech12040061 · Cited by 1
“A crucial component of human biochemical complexity and diversity emerges from microbial complementarity, with distinct microbiomes in upper respiratory [159–163], lower respiratory [115,164–167], and gastrointestinal tracts [166–170] all having tangibly different effects on viral outcomes.”
BackgroundBasic Genetics and Epigenetics of Childhood Lung Disease
Wambach, J., Chaudhari, B. P., & Hamvas, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44887-1.00003-1 · Cited by 1
MICROBIAL PARTNERS IN HEALTH: BROADENING OUR UNDERSTANDING OF HOST-MICROBIOME RELATIONSHIPS
Chewning, S. S. (2018) · Cited by 1
Effects of Various Alpha-1 Antitrypsin Supplement Dosages on the Lung Microbiome and Metabolome
Cickovski, T., Manuel, A. M., Mathee, K., Campos, M., & Narasimhan, G. (2020) · Lecture notes in computer science · doi:10.1007/978-3-030-46165-2_8 · Cited by 2
Kurnia, R. S., & Antarianto, R. D. (2021) · Hosts and Viruses · doi:10.17582/journal.hv/2021/8.1.8.22 · Cited by 1
“Local pH, blood flow, temperature, epithelial cells, oxygen levels, and disposition of inflammatory cells are some conditions that affect the proliferation and dynamic change of the microbial diversity of the respiratory tract (O’Dwyer et al ., 2016).”
Verma, N., Thapa, K., & Dua, K. (2021) · Springer eBooks · doi:10.1007/978-981-33-6827-9_39 · Cited by 1
Immune Suppression in Lung Disease: Lung Transplantation and HIV
McGinniss, J. E., Bernasconi, E., Twigg, H. L., & Morris, A. (2022) · Respiratory medicine · doi:10.1007/978-3-030-87104-8_10 · Cited by 1
Microbiome in Pulmonary Tuberculosis
Rakshit, A., Verma, A., Verma, S., Bhatti, G. K., Khurana, A., Bhatti, J. S., Jawalekar, S. S., & Navik, U. (2022) · Springer eBooks · doi:10.1007/978-981-16-8957-4_11 · Cited by 1
Metadata
- Authors
- O’Dwyer, D. N., Dickson, R. P., & Moore, B. B.
- Affiliations
- Michigan Medicine (US)
- University of Michigan (US)
- Corresponding author
- Moore, Bethany B
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-06
- Volume
- 196
- Issue
- 12
- Pages
- 4839-4847
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC4894335
- OpenAlex
- W2413745624
- Cited by
- 362
- References
- 134
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 31 · 2023: 39 · 2022: 50 · 2021: 55 · 2020: 65 · 2019: 34 · 2018: 26 · 2017: 15 · 2016: 4
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (UL1TR000433)
- National Heart, Lung, and Blood Institute (R01HL115618, L30 HL120241, R01HL119682, K23HL130641, R01HL127805, T32HL007749)
- National Institute of Allergy and Infectious Diseases (R01AI117229)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- lung microbiome, chronic lung disease, dysbiosis, lung immunity, disease exacerbation, host-microbe interactions, bacterial diversity, pathogenesis
- MeSH terms
- Bacteria, Chronic Disease, Homeostasis, Humans, Lung, Lung Diseases, Disease Progression, Host-Pathogen Interactions, Microbiota, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.